| 2022-05-10 |
详情>>
股本变动：
变动后总股本17085.24万股
|
| 2022-05-10 |
详情>>
业绩披露：
2022年一季报每股收益-0.01美元,归母净利润-232.1万美元,同比去年增长-161.19%
|
| 2022-03-03 |
详情>>
业绩披露：
2019年年报每股收益-0.01美元,归母净利润-202.7万美元,同比去年增长68.89%
|
| 2022-03-03 |
详情>>
业绩披露：
2021年年报每股收益0.27美元,归母净利润4628.90万美元,同比去年增长-17.64%
|
| 2022-03-03 |
财报披露：
美东时间 2022-03-03 盘前发布财报
|
| 2021-11-04 |
详情>>
业绩披露：
2021年三季报(累计)每股收益0.08美元,归母净利润1360.60万美元,同比去年增长182.58%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-05 |
详情>>
业绩披露：
2021年中报每股收益0.05美元,归母净利润821.30万美元,同比去年增长4637.57%
|
| 2021-05-06 |
详情>>
业绩披露：
2021年一季报每股收益0.02美元,归母净利润379.30万美元,同比去年增长260.99%
|
| 2021-04-27 |
股东大会：
将于2021-06-10召开股东大会
会议内容 ▼▲
- 1.To elect Anton G. Gueth and Robert P. Roche, Jr. as Class II directors of the Company’s Board of Directors each for a term of three years and until his successor is duly elected and qualified
2.To hold a non-binding, advisory vote to approve our named executive officer compensation as disclosed in this proxy statement.
3.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021
4.To approve and adopt an amendment and restatement of the Company’s Equity Compensation Plan, as amended and restated.
5.To transact such other business that may properly come before the meeting.
|
| 2021-03-02 |
详情>>
业绩披露：
2018年年报每股收益-0.04美元,归母净利润-651.5万美元,同比去年增长61.09%
|
| 2021-03-02 |
详情>>
业绩披露：
2020年年报每股收益0.34美元,归母净利润5620.10万美元,同比去年增长2872.62%
|
| 2020-11-05 |
详情>>
业绩披露：
2020年三季报(累计)每股收益0.03美元,归母净利润481.50万美元,同比去年增长171.63%
|
| 2020-08-06 |
详情>>
业绩披露：
2020年中报每股收益0.00美元,归母净利润-18.1万美元,同比去年增长97.67%
|
| 2020-05-05 |
详情>>
业绩披露：
2020年一季报每股收益-0.01美元,归母净利润-235.6万美元,同比去年增长57.47%
|
| 2020-04-27 |
股东大会：
将于2020-06-11召开股东大会
会议内容 ▼▲
- 1.To elect Leonard S. Jacob, MD, Ph.D. and Peter S. Greenleaf as Class I directors of the Company’s Board of Directors each for a term of three years and until his successor is duly elected and qualified.
2.To hold a non-binding, advisory vote to approve our named executive officer compensation as disclosed in this proxy statement.
3.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2020.
4.To transact such other business that may properly come before the meeting.
|
| 2019-04-26 |
股东大会：
将于2019-06-13召开股东大会
会议内容 ▼▲
- 1.To elect Robert F. Apple, Thomas J. Garrity and Dr. Karen L. Smith as Class III
directors of the Company’s Board of Directors each for a term of three years
and until his or her successor is duly elected and qualified.
2.To hold a non-binding, advisory vote to approve our named executive officer
compensation as disclosed in this proxy statement.
3.To ratify the appointment of KPMG LLP as our independent registered public
accounting firm for our fiscal year ending December 31, 2019.
4.To approve and adopt an amendment and restatement of the Company’s 2008
Equity Compensation Plan, as amended and restated.
5.To transact such other business that may properly come before the meeting.
|
| 2018-04-27 |
股东大会：
将于2018-06-08召开股东大会
会议内容 ▼▲
- 1.To elect Anton G. Gueth and Robert P. Roche, Jr. as Class II directors of the Company’s Board of Directors each for a term of three years and until his successor is duly elected and qualified.
2.To hold a non-binding, advisory vote to approve our named executive officer compensation as disclosed in this proxy statement.
3.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2018.
4.To transact such other business that may properly come before the meeting.
|
| 2016-04-22 |
股东大会：
将于2016-06-02召开股东大会
会议内容 ▼▲
- 1.To elect Robert F. Apple, Thomas J. Garrity and Dr. Jacques Gonella as Class III directors
of the Company’s Board of Directors each for a term of three years and until his successor is duly elected and qualified.
2.To hold a non-binding, advisory vote to approve our named executive officer compensation
as disclosed in this proxy statement.
3.To ratify the appointment of KPMG LLP as our independent registered public accounting
firm for our fiscal year ending December 31, 2016.
4.To approve and adopt an amendment and restatement of the Company’s 2008 Equity Compensation Plan.
5.To approve and adopt an amendment to the Company’s Amended and Restated Certificate
of Incorporation to increase the number of authorized shares of capital stock of the Company from 203,000,000 shares to 303,000,000 shares in order to increase the number of authorized shares of common stock, par value $0.01 per share, of the Company from 200,000,000 shares to 300,000,000 shares.
6.To transact such other business that may properly come before the meeting.
|
| 2015-04-15 |
股东大会：
将于2015-05-28召开股东大会
会议内容 ▼▲
- 1.To elect three directors to Class II of the Company’s Board of Directors for a term of three years.
2.To hold an advisory vote to approve our named executive officer compensation as disclosed in this proxy statement.
3.To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2015.
4.To transact other business that may properly come before the meeting.
|
| 2014-04-16 |
股东大会：
将于2014-05-29召开股东大会
会议内容 ▼▲
- 1. To elect three directors to Class I of the Company’s Board of Directors for a term of three years.
2. To approve an amendment and restatement of the Company’s 2008 Equity Compensation Plan to increase the maximum number of shares authorized for issuance under the plan from 15,000,000 to 21,000,000.
3. To hold an advisory vote to approve our named executive officer compensation as disclosed in this proxy statement.
4. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2014.
5. To transact other business that may properly come before the meeting.
|
| 2013-04-15 |
股东大会：
将于2013-05-22召开股东大会
会议内容 ▼▲
- 1. To elect two directors to Class III of the Company’s Board of Directors for a term of three years and one director to Class I of the Company’s Board of Directors for a term of one year.
2. To approve an amendment and restatement of the Company’s 2008 Equity Compensation Plan to increase the maximum number of shares authorized for issuance under the plan from 13,500,000 to 15,000,000.
3. To approve and adopt an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of common stock, par value $0.01 per share, of the Company from 150,000,000 shares to 200,000,000 shares.
4. To hold an advisory vote to approve our named executive officer compensation as disclosed in this proxy statement.
5. To ratify the appointment of KPMG LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2013.
6. To transact other business that may properly come before the meeting.
|